Dawid P. Grzela
Lodz, LD 92213, Poland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
MULi001-A: Induced pluripotent stem cell line derived from a patient with a germline ETV6 p.Pro214Leu mutation associated with thrombocytopenia and leukemia predisposition.
Journal: Stem cell research
Published: February 05, 2026
In vitro derivation of megakaryocytes and platelets from induced pluripotent stem cells: developmental foundations and translational perspectives.
Journal: Frontiers in immunology
Published: October 07, 2025
mTOR Modulation Affects Galectin-1 Expression in KMT2A-rearranged Acute Lymphoblastic Leukemia Cells.
Journal: Anticancer research
Published: September 19, 2025
Characterization of an induced pluripotent stem cell line (IMBPASi001-A) derived from fibroblasts of a patient affected by Wolfram Syndrome.
Journal: Stem cell research
Published: March 31, 2020
Directed differentiation of human iPSC into insulin producing cells is improved by induced expression of PDX1 and NKX6.1 factors in IPC progenitors.
Journal: Journal of translational medicine
Published: May 25, 2016
EGFR Activation Leads to Cell Death Independent of PI3K/AKT/mTOR in an AD293 Cell Line.
Journal: PloS one
Published: December 02, 2015
IDH1R132H in Neural Stem Cells: Differentiation Impaired by Increased Apoptosis.
Journal: PloS one
Published: September 15, 2015
Generation of human iPSCs from cells of fibroblastic and epithelial origin by means of the oriP/EBNA-1 episomal reprogramming system.
Journal: Stem cell research & therapy
Published: January 29, 2015
Showing 1-11 of 11
Last Updated: 09/26/2026